The article discusses the stigma surrounding cannabis and the importance of destigmatizing it, especially for those who rely on it for medical purposes. The author argues that cannabis should be as socially acceptable as alcohol and emphasizes the need for education on the plant's safety and benefits. Advocacy for cannabis is encouraged, including wearing cannabis-themed apparel and being vocal about its positive aspects. However, the author also acknowledges the potential for abuse and the existence of negative aspects, such as the availability of harmful, illegally produced cannabis. The article calls for a balanced view of cannabis, advocating for its acceptance and legalization while recognizing the need for education and harm reduction.

The article criticizes the stigma surrounding THC, the psychoactive compound in cannabis, contrasting it with the more accepted CBD products. It highlights the medicinal benefits of THC, citing scientific evidence and the World Health Organisation's statements on its low toxicity. The author, Ruby Deevoy, argues that the negative perception of THC is based on misinformation and fear-mongering, and that THC can be safer than alcohol and prescription drugs. The article calls for a reevaluation of drug laws and suggests that regulated, accurately labeled THC products could be used safely and beneficially. It also mentions the work of Kent Scientific Services in testing CBD products and finding many contained illegal levels of THC, which sparked controversy.

The article discusses the historical and contemporary use of cannabis, particularly CBD, in enhancing sexual experiences. It highlights the lack of scientific research in the area but points to anecdotal evidence and limited studies that suggest benefits such as reduced performance anxiety, increased libido, and enhanced pleasure. The article explains how cannabis can alleviate pain during sex, increase blood flow, and potentially improve orgasm intensity. It also touches on the use of cannabis in the LGBTQ+ community, suggesting it can help reduce anxiety and shame associated with sexual activity. The potential of CBD as a natural aphrodisiac and its role in maintaining higher levels of endocannabinoids in the body is also discussed. Additionally, the article mentions the use of CBD-infused products like lubricants to relieve vaginal pain and dryness, and enhance pleasure during sex.

The article discusses the lack of awareness and education regarding the endocannabinoid system (ECS), a major physiological system, among the general public and medical professionals. Despite the ECS's crucial role in health and its interaction with cannabis, only 13% of US medical schools include it in their curriculum. The article highlights the existence of over 41,000 studies on the ECS and cannabis, contradicting the government's claim of insufficient evidence for medical cannabis. It also reveals that endocannabinoid receptors are present in mitochondrial cell walls, emphasizing the importance of a functioning ECS. Additionally, the article notes that other plants besides cannabis can support the ECS and suggests that endocannabinoid deficiency may underlie several 'incurable' conditions, pointing to potential treatment options with cannabinoid therapy. The article encourages self-education and advocates for improved medical training and access to cannabis for therapeutic use.

The article discusses the common issues users face when trying CBD, suggesting that improper use or incorrect product selection may be the cause of unsatisfactory results. It emphasizes the importance of consistency in CBD use, recommending daily intake and microdosing for at least six weeks. The article provides tips to enhance CBD absorption, such as taking it sublingually after eating or brushing teeth, and ensuring a diet rich in healthy fats. It advises on choosing the right CBD product based on individual needs and highlights the potential benefits of full-spectrum CBD. The article also touches on the role of terpenes in enhancing the therapeutic effects of CBD and suggests that those with complex health issues consider getting a medical cannabis prescription. No specific brands or organizations are mentioned, and the article seems to focus on general advice rather than promoting particular products or services.

The article discusses the complexities of cannabis use, acknowledging both its potential for abuse and its benefits for medicinal, spiritual, and recreational purposes. The author argues against the assumption that cannabis advocates are unaware of the risks associated with cannabis use. Dr. Ben Sessa, Chief Medical Officer at AWAKN Life Science Inc, is quoted discussing the multifaceted nature of mental health issues and addictions. The article highlights the dangers of contaminated cannabis in the illegal market and advocates for legalization to ensure quality control and safe usage. It compares the societal acceptance of substances like sugar and alcohol, despite their health risks, to the stigmatization of cannabis. The author concludes that while drug abuse cannot be completely eradicated, legalization and education can help reduce harm and support those struggling with addiction.

The article discusses the safety concerns surrounding over-the-counter medicines like Calpol, highlighting its potential side effects such as liver damage and hyperactivity in children. It contrasts this with the safety profile of medical cannabis, which, despite being treated with caution and skepticism, has been shown to have a low incidence of serious side effects and no recorded deaths. The article criticizes the reliance on Randomised Control Trials for evidence of safety and advocates for the consideration of real-world evidence (RWE). It mentions the UN's reclassification of cannabis and criticizes the UK's National Institute for Health and Care Excellence (NICE) for not considering RWE. The article also touches on the negative consequences of cannabis prohibition in the UK, such as unsafe self-medication, unregulated products, lack of education, and legal repercussions.

The article discusses the differences in effects between smoking cannabis and consuming cannabis edibles, such as brownies. It explains that edibles can produce a stronger high due to the presence of THC and its conversion to 11-hydroxy-THC when digested. The article highlights the importance of consuming edibles slowly due to their unpredictable potency and individual metabolism rates. It also touches on the medicinal benefits of various types of THC, including THCA, THCV, Delta-8 THC, and Delta-9 THC. The piece emphasizes that while edibles take longer to take effect, they can offer more effective and longer-lasting results due to the way cannabinoids are processed in the body. The article advises caution when trying edibles for the first time, suggesting that users start with small amounts to avoid overwhelming experiences.

A study by Drug Science has found that whole plant cannabis oil significantly reduces seizure frequency in children with severe, treatment-resistant epilepsy, with an 86% reduction observed. The study highlights the potential of cannabis oil, which includes THC, to outperform other epilepsy drugs and even lead to some patients becoming seizure-free. Despite the evidence and the UK's status as a major medical cannabis exporter, NHS prescriptions for whole plant cannabis are rare, with only three issued since a 2018 law change. The cost of private prescriptions is prohibitively expensive for many families. The article discusses barriers to wider NHS access, including pharmaceutical industry resistance, educational gaps in medical training, and regulatory challenges. It also touches on the broader implications for the healthcare system and the potential benefits of medical cannabis for various conditions.

The article discusses the widespread issue of sleep deprivation and chronic insomnia in the UK, highlighting that a significant portion of the population does not get the recommended 8 hours of sleep per night. It explores the potential of CBD (Cannabidiol) as a natural remedy for sleep problems, focusing on its interaction with serotonin receptors and the endocannabinoid system. The article suggests that CBD may help regulate serotonin levels, which in turn can aid in the production of melatonin, a hormone that regulates sleep. It also addresses the relationship between stress and sleep, noting that CBD may help manage stress by supporting the body's endocannabinoid system. The piece advocates for the use of CBD oil, and possibly CBDA, as a daily supplement to potentially improve sleep quality.